Literature DB >> 23238059

Long-term intake of sesamin improves left ventricular remodelling in spontaneously hypertensive rats.

Wen-xing Li1, Xiang Kong, Jun-xiu Zhang, Jie-ren Yang.   

Abstract

This study was designed to evaluate the in vivo cardioprotective effects of food-derived sesamin in spontaneously hypertensive rats (SHR). The study was performed with 17-week-old male normotensive Wistar-Kyoto rats (WKY) and SHR which are untreated or treated with orally administered sesamin for 16 weeks before they were sacrificed. Long-term treatment with sesamin obviously improved left ventricular (LV) hypertrophy and fibrosis in SHR, as indicated by the decrease of LV weight/body weight, myocardial cell size, cardiac fibrosis and collagen type I expression as well as the amelioration of the LV ultrastructure. These effects were associated with reduced systolic blood pressure, enhanced cardiac total antioxidant capability and decreased malondialdehyde content, nitrotyrosine level and transforming growth factor β1 (TGF-β1) expression. All these results suggest that chronic treatment with sesamin improves LV remodeling in SHR through alleviation of oxidative and nitrative stress, reduction of blood pressure and downregulation of TGF-β1 expression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23238059     DOI: 10.1039/c2fo30220a

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  9 in total

1.  Effect of spironolactone on cardiac remodeling after acute myocardial infarction.

Authors:  Chun-Tao Wu; Zhong-Hua Wang; Zhu-Qin Li; Lan-Feng Wang
Journal:  World J Emerg Med       Date:  2013

Review 2.  Research progress of cardioprotective agents for prevention of anthracycline cardiotoxicity.

Authors:  Jing Zhang; Xiaohai Cui; Yan Yan; Min Li; Ya Yang; Jiansheng Wang; Jia Zhang
Journal:  Am J Transl Res       Date:  2016-07-15       Impact factor: 4.060

3.  Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.

Authors:  Mengqiu Zhao; Shuguo Zheng; Jieren Yang; Yuanjie Wu; Younan Ren; Xiang Kong; Wei Li; Jiali Xuan
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

Review 4.  Effects of Polyphenols on Oxidative Stress-Mediated Injury in Cardiomyocytes.

Authors:  Rosanna Mattera; Monica Benvenuto; Maria Gabriella Giganti; Ilaria Tresoldi; Francesca Romana Pluchinotta; Sonia Bergante; Guido Tettamanti; Laura Masuelli; Vittorio Manzari; Andrea Modesti; Roberto Bei
Journal:  Nutrients       Date:  2017-05-20       Impact factor: 5.717

5.  Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction.

Authors:  Tran Duong Thuy; Nam Nhut Phan; Chih-Yang Wang; Han-Gang Yu; Shu-Yin Wang; Pung-Ling Huang; Yi-Yin Do; Yen-Chang Lin
Journal:  Mol Med Rep       Date:  2017-03-30       Impact factor: 2.952

6.  Bisphenol A-induced oxidative damage in the hepatic and cardiac tissues of rats: The modulatory role of sesame lignans.

Authors:  Saber M Eweda; Al Sayeda A Newairy; Heba M Abdou; Assmaa S Gaber
Journal:  Exp Ther Med       Date:  2019-11-13       Impact factor: 2.447

7.  Effect and Mechanism of Lidocaine Pretreatment Combined with Dexmedetomidine on Oxidative Stress in Patients with Intracranial Aneurysm Clipping.

Authors:  Junting Zhang; Hongwei Zhang; Liang Zhao; Zhanqi Zhao; Ying Liu
Journal:  J Healthc Eng       Date:  2021-11-24       Impact factor: 2.682

Review 8.  Sesame (Sesamum indicum L.): A Comprehensive Review of Nutritional Value, Phytochemical Composition, Health Benefits, Development of Food, and Industrial Applications.

Authors:  Panpan Wei; Fenglan Zhao; Zhen Wang; Qibao Wang; Xiaoyun Chai; Guige Hou; Qingguo Meng
Journal:  Nutrients       Date:  2022-09-30       Impact factor: 6.706

9.  Self-Nanoemulsifying Drug Delivery Systems for Enhancing Solubility, Permeability, and Bioavailability of Sesamin.

Authors:  Chih-Yuan Wang; Ching-Chi Yen; Mei-Chich Hsu; Yu-Tse Wu
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.